Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms
- 1 December 2001
- Vol. 58 (6) , 960-963
- https://doi.org/10.1016/s0090-4295(01)01442-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasiaUrology, 2000
- Phytotherapeutic agents in the treatment of lower urinary tract symptoms: a demographic analysis of awareness and use at the University of ChicagoUrology, 1999
- Saw Palmetto Extracts for Treatment of Benign Prostatic HyperplasiaJAMA, 1998
- Alternative Medicine — The Risks of Untested and Unregulated RemediesNew England Journal of Medicine, 1998
- Why Patients Use Alternative MedicineJAMA, 1998
- A brief male sexual function inventory for urologyUrology, 1995
- Placebo-Controlled Evaluation of the Efficacy and Tolerability of Permixon® in Benign Prostatic Hyperplasia after Exclusion of Placebo RespondersClinical Drug Investigation, 1995
- Growing Use of Medicinal Botanicals Forces Assessment by Drug RegulatorsJAMA, 1995
- The Value of Permixon in Benign Prostatic HypertrophyBritish Journal of Urology, 1986
- A double‐blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.British Journal of Clinical Pharmacology, 1984